HypertensionRandomised controlled trial
Targeting better hypertension control with the usage of the European Society of Hypertension (ESH) smartphone application
- Randomised controlled trial
- two-arm
Authors' conclusion
Follow-up of hypertensive patients with the ESH Care App is feasible and contributes to a significantly better office and out-of-office BP control after 6 months.
Study context
- Population
- Hypertensive patients with uncontrolled office (≥140/90 mmHg) and 24-h ambulatory blood pressure (BP) (≥130/80 mmHg) after antihypertensive drug initiation or intensification
- Participants
- 107 patients
- Comparison
- App-assisted strategy vs usual care
Primary result
As reported in the abstract
Achievement of both systolic and diastolic ambulatory BP targets (<130/80 mmHg) · 6 months
P = 0.002
Further findings
| Outcome | AAS | Usual care |
|---|---|---|
| Office BP reduction (SBP/DBP) · 6 months | mean reduction 25.1/16.3 (SD 6.4/6.3) mmHg | mean reduction 19.9/12.4 (SD 9.1/7.7) mmHg |
| Ambulatory BP reduction (SBP/DBP) · 6 months | mean reduction 10.9/6.4 (SD 9.1/5.5) mmHg | mean reduction 6.6/3.3 (SD 9.2/6.2) mmHg |
Original publication
Targeting better hypertension control with the usage of the ESH smartphone application. Eur J Prev Cardiol. Published 24 April 2025. doi:10.1093/eurjpc/zwaf240
Summarised from the published abstract; every number is checked against it